IMMUNEOS Trademark
Trademark Overview
On Wednesday, December 24, 2025, a trademark application was filed for IMMUNEOS with the United States Patent and Trademark Office. The USPTO has given the IMMUNEOS trademark a serial number of 99564552. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, May 26, 2026. This trademark is owned by Immunevax. The IMMUNEOS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Scientific research consultancy; Providing scientific research information; Providing medical and scientific research information; Blood analysis for scientific research purposes; Blood testing for scientific research purposes; Providing information about medical and scientific research; Scientific research in the field of quantum computing; Providing scientific research information in the field of pharmaceuticals; Scientific research and development in the field of mRNA drugs; Providing medical research and scientific research information in the field of oncology via the Internet; Medical and scientific research in the field of cancer treatment and diagnosis; Scientific research in the nature of conducting clinical trials for others; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing reagent sample testing and diagnostic services for others...
General Information
| Serial Number | 99564552 |
| Word Mark | IMMUNEOS |
| Filing Date | Wednesday, December 24, 2025 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, May 26, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 26, 2026 |
Trademark Statements
| Goods and Services | Scientific research consultancy; Providing scientific research information; Providing medical and scientific research information; Blood analysis for scientific research purposes; Blood testing for scientific research purposes; Providing information about medical and scientific research; Scientific research in the field of quantum computing; Providing scientific research information in the field of pharmaceuticals; Scientific research and development in the field of mRNA drugs; Providing medical research and scientific research information in the field of oncology via the Internet; Medical and scientific research in the field of cancer treatment and diagnosis; Scientific research in the nature of conducting clinical trials for others; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing reagent sample testing and diagnostic services for others for scientific research purposes; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Medical and scientific research, namely, conducting clinical trials for others; Scientific and technological services, namely, research and design in the field of integrated system architecture that allows for the rapid development of highly interactive and customizable learning applications |
| Pseudo Mark | IMMUNE OS |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, December 24, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | Wednesday, November 12, 2025 |
| First Use In Commerce Date | Wednesday, November 12, 2025 |
Trademark Owner History
| Party Name | Immunevax |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Marietta, GA 30066
US |
| Party Name | Immunevax |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Marietta, GA 30066
US |
Trademark Events
| Event Date | Event Description |
| Wednesday, December 24, 2025 | NEW APPLICATION ENTERED |
| Wednesday, December 24, 2025 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, April 15, 2026 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, April 27, 2026 | ASSIGNED TO EXAMINER |
| Friday, May 1, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, May 20, 2026 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, May 26, 2026 | PUBLISHED FOR OPPOSITION |
| Tuesday, May 26, 2026 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
